Inovio Pharmaceuticals Inc (INO)
1.79
-0.04
(-2.19%)
USD |
NASDAQ |
Dec 23, 13:44
Inovio Pharmaceuticals Cash from Investing (Quarterly): 14.08M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Novavax Inc | 31.91M |
| Baxter International Inc | -164.00M |
| Candel Therapeutics Inc | 0.00 |
| AIM ImmunoTech Inc | 0.334M |
| Protalix BioTherapeutics Inc | 20.33M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -27.44M |
| Cash from Financing (Quarterly) | 0.6606M |
| Free Cash Flow | -111.18M |
| Free Cash Flow Per Share (Quarterly) | -0.9752 |
| Free Cash Flow Yield | -245.1% |